AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 296: E513-E519, 2009. First published January 6, 2009; doi:10.1152/ajpendo.90497.2008
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/E513    most recent
90497.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lumbers, E. R.
Right arrow Articles by Owens, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lumbers, E. R.
Right arrow Articles by Owens, J. A.

Effects of intrafetal IGF-I on growth of cardiac myocytes in late-gestation fetal sheep

Eugenie R. Lumbers,1 Min young Kim,1 Judith H. Burrell,1 Vasumathy Kumarasamy,1 Amanda C. Boyce,1 Karen J. Gibson,1 Kathryn L. Gatford,2 and Julie A. Owens2

1Department of Physiology and Pharmacology, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney; and 2Discipline of Obstetrics and Gynecology, School of Pediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia

Submitted 7 June 2008 ; accepted in final form 4 January 2009

Intrafetal insulin-like growth factor (IGF)-I promotes cardiac hypertrophy in the late-gestation fetal sheep; whether these effects are sustained is unknown. IGF-I was infused for 4 days at 80 µg/h from 121 to 125 days of gestation, and its effects at 128 days, 3 days after the infusion stopped, were determined by comparison with untreated fetal sheep. After IGF-I treatment, fetal weights were similar to those in control fetuses but kidney weights were bigger (P < 0.05), as were spleen weights of male fetuses (P < 0.05). Cardiac myocytes were larger in female than male fetal sheep (P < 0.001). IGF-I increased male (P < 0.001) but not female myocyte volumes. IGF-I did not alter the proportions of uni- or binucleated right or left ventricular myocytes. Female fetal sheep had a greater proportion of binucleated cardiac myocytes than males (P < 0.05). IGF-I-treated fetuses had a slightly greater proportion of right ventricular nuclei in cell cycle phase G2/M and a reduced proportion of G0/G1 phase nuclei (P < 0.1). Therefore, evidence for IGF-I-stimulated cardiac cell hyperplasia in fetal sheep in late gestation was limited. In conclusion, the greater sizes and larger proportion of binucleated cardiac myocytes in female fetal sheep suggest that myocyte maturation may occur earlier in females than in males. This may explain in part the male sex-specific responsiveness of cardiac hypertrophy to IGF-I in late gestation. If IGF-I-stimulated cardiomyocyte growth is accompanied by maturation of contractile function, IGF-I may be a potential therapeutic agent for maintaining cardiac output in preterm males.

insulin-like growth factor-I; hypertrophy; sex; heart



Address for reprint requests and other correspondence: E. R. Lumbers, Dept. of Physiology and Pharmacology, School of Medical Sciences, Univ. of New South Wales, Sydney, Australia 2052 (e-mail: e.lumbers{at}unsw.edu.au)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.